Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
BBIOBridgeBio Pharma, Inc.
| Figure | BBIOBridgeBio Pharma, Inc.FY2025 · Dec |
|---|---|
| Revenue | $502.08M |
| Revenue, yoy | +126.3% |
| Net income | $724.93M |
| Net income, yoy | −35.3% |
| Net margin | -144.4% |
| Free cash flow | $447.01M |
| FCF margin | -89.0% |
| EPS, diluted | $3.78 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed